1. Acid-Suppressive Therapy and Risk of Infections: Pros and Cons

   • Leon Fisher
   • Alexander Fisher

   Review Article 30 March 2017 Pages: 587 - 624

   

2. Current Clinical Trials on the Use of Ceftaroline in the Pediatric Population

   • Adam Corey
   • Tsz-Yin So

   Review Article 05 April 2017 Pages: 625 - 634

3. Efficacy of Interferon-Free Therapies for Chronic Hepatitis C: A Systematic Review of All Randomized Clinical Trials

   • Vinicius L. Ferreira
   • Fernanda S. Tonin
   • Roberto Pontarolo

   Systematic Review 13 April 2017 Pages: 635 - 646

   

4. Exposure–Safety Response Relationship for Ombitasvir, Paritaprevir/Ritonavir, Dasabuvir, and Ribavirin in Patients with Chronic Hepatitis C Virus Genotype 1 Infection: Analysis of Data from Five Phase II and Six Phase III Studies

   • Chih-Wei Lin
   • Rajeev Menon
   • Sandeep Dutta

   Original Research Article 04 April 2017 Pages: 647 - 657

   

5. The Effect of Single and Multiple Doses of Rifampin on the Pharmacokinetics of Doravirine in Healthy Subjects

   • Ka Lai Yee
   • Sauzanne G. Khalilieh
   • Joan R. Butterton

   Original Research Article 28 March 2017 Pages: 659 - 667

   

6. Relationship Between the Expression of O⁶-Methylguanine-DNA Methyltransferase (MGMT) and p53, and the Clinical Response in Metastatic Pancreatic Adenocarcinoma Treated with FOLFIRINOX

   • Carole Vitellius
   • Caroline Eymerit-Morin
   • François-Xavier Caroli-Bosc

   Original Research Article 18 April 2017 Pages: 669 - 677

   

7. Evaluation of the Pharmacokinetics and Pharmacodynamics of Prasugrel in Japanese Elderly Subjects

   • Tomoko Hasunuma
   • Hiroyuki Fukase
   • Yasuhiro Nishikawa

   Original Research Article Open access 17 April 2017 Pages: 679 - 685

   

8. Disease Burden, Early Discontinuation, and Healthcare Costs in Hepatitis C Patients with and without Chronic Kidney Disease Treated with Interferon-Free Direct-Acting Antiviral Regimens

   • Amy Puenpatom
   • Michael Hull
   • Kay Schwebke

   Original Research Article Open access 06 April 2017 Pages: 687 - 697

   

9. Oral Teicoplanin as an Alternative First-Line Regimen in Clostridium difficile Infection in Elderly Patients: A Case Series

   • Benjamin Davido
   • Céline Leplay
   • Hugues Michelon

   short communication 06 April 2017 Pages: 699 - 703

   

10. Long Pulmonary Residence Time and Plasma Half-Life of Tiotropium: Implications for Pharmacokinetic Bioequivalence Studies

    • Ashish Sharma
    • Benjamin Weber
    • Bernd Meibohm

    Letter to the Editor 01 June 2017 Pages: 705 - 707

    

11. Response to Sharma et al.: Long Pulmonary Residence Time and Plasma Half-Life of Tiotropium: Implications for Pharmacokinetic Bioequivalence Studies

    • Jaime Algorta

    Letter to the Editor 02 June 2017 Pages: 709 - 710

12. Erratum to: Surfactants in Acute Respiratory Distress Syndrome in Infants and Children: Past, Present and Future

    • Angela Amigoni
    • Andrea Pettenazzo
    • Maria Circelli

    Erratum 06 June 2017 Pages: 711 - 711